https://www.benzinga.com/analyst-ratings/analyst-color/23/08/33754935/boston-scientifics-farapulse-eyes-stronger-us-market-position-with-potential-fda-ap
Boston Scientific's Farapulse Eyes Stronger US Market Position With Potential FDA Approval - Boston...
Aug 11, 2023 - Boston Scientific Corp (NYSE: BSX) will present results from ADVENT pivotal trial for its Farapulse Pulsed Field Ablation (PFA) system at the 2023 European...